CTS Corp. (CTS) Tops Q4 EPS by 10c, Revenues Beat; Offers FY21 EPS

February 9, 2021 7:38 AM EST
Get Alerts CTS Hot Sheet
Price: $30.85 +0.55%

EPS Growth %: +16.2%

Financial Fact:
Net sales: 99.7M

Today's EPS Names:
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

CTS Corp. (NYSE: CTS) reported Q4 EPS of $0.43, $0.10 better than the analyst estimate of $0.33. Revenue for the quarter came in at $123 million versus the consensus estimate of $117.02 million.

“We saw strength in most end markets and executed well to deliver solid financial results in the fourth quarter,” said Kieran O’Sullivan, CEO of CTS Corporation. “We are making progress on our Focus 2025 strategic initiative, including a target of 10% annualized revenue growth. The recent SSI acquisition strengthens our position with medical customers and advances our end market diversification.”


CTS Corp. sees FY2021 EPS of $1.20-$1.60, versus the consensus of $1.41.

For earnings history and earnings-related data on CTS Corp. (CTS) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Earnings, Guidance, Management Comments

Related Entities

Earnings, Definitive Agreement